• DBV Technologies Stock Bounces Back 4%, Recording One of the Top Gains in the SBF 120 Idéal Investisseur Wed, 08 Jul 2026 10:35:00 GMT
• Citizens JMP Maintains DBV Technologies(DBVT.US) With Buy Rating, Maintains Target Price $55 富途牛牛 Tue, 07 Jul 2026 16:56:43 GMT
• Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF GlobeNewswire Mon, 06 Jul 2026 20:30:00 GMT
• DBV Technologies posts half-year liquidity contract figures Stock Titan Mon, 06 Jul 2026 20:30:00 GMT
• DBV Technologies Stock Drops Over 2% and Breaks Its Support at €2.75 Idéal Investisseur Thu, 02 Jul 2026 11:32:00 GMT
• Guggenheim Maintains DBV Technologies(DBVT.US) With Buy Rating, Maintains Target Price $51 富途牛牛 Wed, 01 Jul 2026 13:35:01 GMT
• A Quick Look at Today's Ratings for DBV Technologies(DBVT.US), With a Forecast Between $40 to $55 Moomoo Wed, 01 Jul 2026 13:00:01 GMT
• DBV Technologies Stock Rebounds Over 3%, Among Top Gainers in SBF 120 Idéal Investisseur Wed, 01 Jul 2026 08:59:00 GMT
• DBVT: Analyst Maintains Overweight Rating with Revised Applicati GuruFocus Wed, 01 Jul 2026 04:05:33 GMT
• Enterprise value to revenue forward of DBV Technologies SA – FWB:DBV TradingView Tue, 30 Jun 2026 20:02:18 GMT
• DBVT Maintains Market Outperform Rating -- Price Target Raised t GuruFocus Tue, 30 Jun 2026 15:23:13 GMT
• DBVT, DBV Technologies Updates Biologics License Application Pro GuruFocus Tue, 30 Jun 2026 15:23:11 GMT
• DBV Technologies pushes back by a quarter its marketing authorization application marketscreener.com Tue, 30 Jun 2026 14:38:22 GMT
• dbvt: analyst maintains overweight rating with revised applicati GuruFocus Tue, 30 Jun 2026 12:48:09 GMT
• Optimism Surrounding DBV Technologies (DBVT) Despite Submission Delay GuruFocus Tue, 30 Jun 2026 11:01:43 GMT
• dbvt q1 2026 earnings: eps misses estimates as company continues r&d focus without revenue - operating margin analysis dars.gov.et Tue, 30 Jun 2026 10:30:33 GMT
• DBV Technologies Shares Drop Nearly 5%, Falling Below €2.75 Idéal Investisseur Tue, 30 Jun 2026 09:46:00 GMT
• DBV Technologies: FDA Submission for Viaskin Peanut Scheduled for Q3 2026 Idéal Investisseur Tue, 30 Jun 2026 07:00:00 GMT
• dbv technologies plans q3 filing of us regulatory application for viaskin peanut patch Moomoo Tue, 30 Jun 2026 03:30:28 GMT
• dbv technologies delays viaskin peanut patch bla submission to q3 2026 after fda feedback collaboration 1 Minichart Tue, 30 Jun 2026 01:45:00 GMT
• dbvt's update on viaskin peanut patch bla submission for young c GuruFocus Mon, 29 Jun 2026 20:55:45 GMT
• dbv expects viaskin peanut patch bla submission in q3 after fda feedback marketscreener.com Mon, 29 Jun 2026 20:50:10 GMT
• DBV Technologies to file VIASKIN Peanut Patch BLA in Q3 2026 after FDA feedback TradingView Mon, 29 Jun 2026 20:33:01 GMT
• DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collabor... GlobeNewswire Mon, 29 Jun 2026 20:00:00 GMT
• dbv technologies stock rebounds nearly 4% and crosses its mm20 Idéal Investisseur Mon, 29 Jun 2026 09:04:00 GMT
• DBV Technologies Plans Q3 Filing of US Regulatory Application for Viaskin Peanut Patch Moomoo Mon, 29 Jun 2026 07:00:00 GMT
• DBV Technologies (NASDAQ: DBVT) targets Q3 2026 for VIASKIN Peanut BLA filing Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• DBV Technologies delays BLA filing for VIASKIN® Peanut Patch in kids 4-7 to Q3 2026 after FDA feedback. Pluang Mon, 29 Jun 2026 07:00:00 GMT
• enterprise value to revenue forward of dbv technologies sa – mun:dbv TradingView Fri, 26 Jun 2026 08:38:18 GMT
• DBV Technologies Stock Falls by 2.77%, Breaking Its Support at €2.75 Idéal Investisseur Fri, 26 Jun 2026 07:00:00 GMT
• dbvt q1 2026 earnings: wider-than-expected loss but stock gains on pipeline progress - estimate dispersion dars.gov.et Thu, 25 Jun 2026 22:43:00 GMT
• enterprise value to revenue forward of dbv technologies sa – gettex:dbv TradingView Thu, 25 Jun 2026 21:20:29 GMT
• price to sales forward of dbv technologies sa – euronext:dbv TradingView Thu, 25 Jun 2026 09:34:56 GMT
• enterprise value to ebit forward of dbv technologies sa – euronext:dbv TradingView Thu, 25 Jun 2026 09:00:41 GMT
• price to book forward of dbv technologies sa – euronext:dbv TradingView Thu, 25 Jun 2026 08:58:30 GMT
• price to earnings forward of dbv technologies sa – euronext:dbv TradingView Thu, 25 Jun 2026 01:46:48 GMT
• dbv technologies (dbvt) soars 5.3%: is further upside left in the stock? MSN Wed, 24 Jun 2026 16:39:12 GMT
• dbv technologies joins euronext tech leaders index as of june 22 Idéal Investisseur Wed, 24 Jun 2026 07:00:00 GMT
• dbv technologies sa (dbvt) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index GlobeNewswire Tue, 23 Jun 2026 07:00:00 GMT
• Peanut Allergy Market to Witness Transformational Growth Opportunities by 2034 – DelveInsight | Stallergenes Greer, Roch, DBV Tech... Barchart.com Tue, 23 Jun 2026 07:00:00 GMT
• DBV Technologies Shares Rise 3.4% as Momentum Builds Toward Resistance - Factor Momentum dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• dbv technologies sa (dbvt) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• dbv technologies sa (dbvt) financial health: profitability & balance sheet analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• dbv technologies sa (dbvt) valuation: pe, pb & fair value analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• dbv technologies sa (dbvt) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• dbv technologies (dbvt) soars 5.3%: is further upside left in the stock? MSN Fri, 19 Jun 2026 18:03:36 GMT
• dbv technologies shares drop 2.5% and test €2.75 support level Idéal Investisseur Fri, 19 Jun 2026 07:00:00 GMT
• dbv technologies sa (dbvt) risk assessment: volatility, financial risk & investment risk TradingKey Fri, 19 Jun 2026 05:21:01 GMT
• dbv technologies sa (dbvt) valuation: pe, pb & fair value analysis TradingKey Fri, 19 Jun 2026 01:31:57 GMT
• dbv technologies sa (dbvt) earnings forecast: future eps & revenue growth estimates TradingKey Fri, 19 Jun 2026 00:43:43 GMT
• Dbv Technologies SA (DBVT) Financial Health: Profitability & Balance Sheet Analysis TradingKey Fri, 19 Jun 2026 00:13:33 GMT
• dbv technologies (dbvt) soars 5.3%: is further upside left in the stock? MSN Wed, 17 Jun 2026 12:11:50 GMT
• dbv technologies sa (dbvt) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 09:02:21 GMT
• Dbv Technologies SA (DBVT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 08:57:18 GMT
• dbv technologies sa (dbvt) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 08:24:57 GMT
• dbv technologies (enxtpa:dbv) advances peanut patch with new phase 3 data and infant trial Yahoo Finance Wed, 17 Jun 2026 07:00:00 GMT
• dbv technologies sa (dbvt) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• dbv technologies sa (dbvt) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• dbv technologies (dbvt) soars 5.3%: is further upside left in the stock? MSN Tue, 16 Jun 2026 18:40:05 GMT
• dbv technologies sa (dbvt) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock? Yahoo Finance Mon, 15 Jun 2026 07:00:00 GMT
• dbv technologies announces the results of its 2026 combined general meeting 富途牛牛 Sun, 14 Jun 2026 21:37:05 GMT
• Trial of Peanut Patch in Babies Launches, With Hope for Tolerance Allergic Living Fri, 12 Jun 2026 07:00:00 GMT
• DBV Technologies Stock Rebounds Nearly 2% at €2.75 Support Idéal Investisseur Fri, 12 Jun 2026 07:00:00 GMT
• DBV Technologies Screens First Infant in THRIVE Peanut Patch Trial HCP Live Thu, 11 Jun 2026 07:00:00 GMT
• DBV Technologies: JP Morgan Chase Falls Below 10% Threshold marketscreener.com Thu, 11 Jun 2026 07:00:00 GMT
• DBV Technologies Stock Rebounds on its €2.75 Support Following the VITESSE Study Idéal Investisseur Thu, 11 Jun 2026 07:00:00 GMT
• dbv technologies revises participation at goldman sachs global healthcare conference due to ceo travel issue. Pluang Tue, 09 Jun 2026 11:48:10 GMT
• DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference GlobeNewswire Tue, 09 Jun 2026 07:00:00 GMT
• DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress... The Manila Times Tue, 09 Jun 2026 07:00:00 GMT
• DBV Technologies: VITESSE Delivers Positive Results, THRIVE Presented at EAACI Idéal Investisseur Tue, 09 Jun 2026 07:00:00 GMT
• DBV Technologies Stock Breaks Key Support and Slides Over 2% Idéal Investisseur Tue, 09 Jun 2026 07:00:00 GMT
• new positive data for viaskin peanut (dbv technologies) marketscreener.com Tue, 09 Jun 2026 07:00:00 GMT
• DBV Technologies to Present New Positive Data from VITESSE GlobeNewswire Mon, 08 Jun 2026 07:00:00 GMT
• DBV Technologies: Daniel Tassé to Speak on June 9 at 9:20 AM at the Goldman Sachs Global Healthcare Conference in Miami Idéal Investisseur Mon, 08 Jun 2026 07:00:00 GMT
• peanut patch helps allergic kids with asthma and eczema in trial Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• dbv's moment of truth: a patch, a promise, and a high-stakes pitch BriefGlance Fri, 05 Jun 2026 20:30:00 GMT
• dbv technologies ceo joins goldman sachs global healthcare fireside chat Stock Titan Fri, 05 Jun 2026 20:30:00 GMT
• db grants 4,060,000 psus to ceo daniel tassé tied to fda approvals of viaskin peanut TradingView Fri, 05 Jun 2026 20:03:01 GMT
• DBV Technologies (NASDAQ: DBVT) ties 4,060,000 CEO PSUs to FDA milestones Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• DBV Technologies Shares Drop Nearly 4% Breaking Below 200-Day Moving Average Idéal Investisseur Fri, 05 Jun 2026 07:00:00 GMT
• dbv technologies to participate in the goldman sachs 47th annual global healthcare conference GlobeNewswire Fri, 05 Jun 2026 07:00:00 GMT
• DBV Technologies Shareholders Approve Governance and Capital Measures The Globe and Mail Thu, 04 Jun 2026 07:00:00 GMT
• DBV's Moment of Truth: A Patch, a Promise, and a High-Stakes Pitch BriefGlance Thu, 04 Jun 2026 06:38:42 GMT
• shareholders sign off on every proposal at dbv technologies 2026 meeting Stock Titan Wed, 03 Jun 2026 20:30:00 GMT
• bv technologies screens first infant in viaskin peanut patch study grafa.com Wed, 03 Jun 2026 09:46:58 GMT
• DBV Technologies Launches THRIVE Trial of VIASKIN Peanut Patch in Infants The Clinical Trial Vanguard Wed, 03 Jun 2026 07:00:00 GMT
• dbv technologies announces the results of its 2026 combined general meeting GlobeNewswire Wed, 03 Jun 2026 07:00:00 GMT
• information regarding the total number of voting rights and total number of shares of the company as of may 31, 2026 Yahoo Finance UK Wed, 03 Jun 2026 07:00:00 GMT
• dbv technologies (nasdaq: dbvt) shareholders back bylaw changes at 2026 meeting Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• dbv technologies expands viaskin peanut program to infants with peanut allergies Idéal Investisseur Wed, 03 Jun 2026 07:00:00 GMT
• dbv technologies enrolls first patient in clinical study marketscreener.com Wed, 03 Jun 2026 07:00:00 GMT
• portzamparc maintains 'add' rating on dbv technologies marketscreener.com Wed, 03 Jun 2026 07:00:00 GMT
• dbv technologies details share count, voting rights as of may 31 Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• dbv technologies begins phase 2 trial of viaskin peanut patch for infants with peanut allergy. Pluang Wed, 03 Jun 2026 03:15:11 GMT
• dbv technologies starts phase 2 trial for viaskin peanut patch in infants with peanut allergy. Pluang Wed, 03 Jun 2026 02:42:04 GMT
• dbv technologies screens first infant for thrive phase 2 peanut allergy trial geneonline.com Wed, 03 Jun 2026 00:22:24 GMT
• dbv technologies announces first participant screened in thrive phase 2 study of the viaskin® peanut patch in infants ages 6 throu... The Manila Times Wed, 03 Jun 2026 00:01:17 GMT
• DBV Technologies Announces First Participant Screened in GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• Peanut-allergic babies enter THRIVE study for skin patch therapy Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• DBV Technologies Screens First Infant for THRIVE Phase 2 Peanut Allergy Trial geneonline.com Tue, 02 Jun 2026 07:00:00 GMT
• DBV Technologies Breaks Key Support Ahead of Its General Meeting Idéal Investisseur Tue, 02 Jun 2026 07:00:00 GMT
• dbv technologies starts phase 2 trial for viaskin peanut patch in infants with peanut allergy. Pluang Tue, 02 Jun 2026 07:00:00 GMT
• dbv technologies begins phase 2 trial of viaskin peanut patch for infants with peanut allergy. Pluang Tue, 02 Jun 2026 07:00:00 GMT
• dbv technologies shares drop nearly 4% following a challenging month Idéal Investisseur Mon, 01 Jun 2026 11:08:00 GMT
• food allergy market expected to experience accelerated growth and market evolution by 2036 – delveinsight | novartis, roche, ars p... Barchart.com Mon, 01 Jun 2026 07:00:00 GMT
• A Look At DBV Technologies (ENXTPA:DBV) Valuation After Recent Share Price Moves And Conflicting Signals simplywall.st Sat, 30 May 2026 07:00:00 GMT
• dbv technologies stock: -16% in three months, eyeing support at €3.19 Idéal Investisseur Tue, 26 May 2026 07:00:00 GMT
• dbv technologies: j.p. morgan chase falls below 10% threshold in capital and voting rights marketscreener.com Mon, 25 May 2026 13:37:24 GMT
• earnings preview: dbvt to report financial results on april 30 Moomoo Fri, 22 May 2026 19:34:39 GMT
• dbv technologies stock rebounds 2% after prolonged decline Idéal Investisseur Fri, 22 May 2026 07:00:00 GMT
• dbv: skin patch for peanut allergy nears fda filing, with pipeline expansion underway TradingView Tue, 19 May 2026 13:38:54 GMT
• dbv: skin-based immunotherapy for peanut allergy nears fda filing, with pipeline and market expansion ahead TradingView Tue, 19 May 2026 07:00:00 GMT
• dbv technologies s.a. - american depositary shares (nq: dbvt The Chronicle-Journal Fri, 15 May 2026 20:00:01 GMT
• mpm bioimpact reports 8.8% stake in dbv technologies (dbvt) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• DBV Technologies Shares at €3.44: Up 77% Over the Year, Heading to the June 3rd General Meeting Idéal Investisseur Thu, 14 May 2026 07:00:00 GMT
• dbv technologies s.a. stock 12‑month price target raised to $40.96, implies 109% upside TradingView Thu, 14 May 2026 07:00:00 GMT
• dbv technologies s.a. - american depositary shares (nq: dbvt FinancialContent Thu, 14 May 2026 01:36:39 GMT
• dbv technologies shares drop 2% to €3.41 but maintain a +75% yearly gain Idéal Investisseur Wed, 13 May 2026 07:00:00 GMT
• adage insiders report 22,272,884 shares in dbv technologies (nasdaq: dbvt) Stock Titan Wed, 13 May 2026 07:00:00 GMT
• artisan partners (dbvt) discloses 2,219,386 ads; 3.7% stake reported Stock Titan Wed, 13 May 2026 07:00:00 GMT
• dbv technologies to participate in the h.c. wainwright 4th annual bioconnect investor conference at nasdaq The Manila Times Wed, 13 May 2026 07:00:00 GMT
• vivo opportunity (dbvt) holds 2.36m adss — 4.0% ownership disclosed Stock Titan Wed, 13 May 2026 02:15:41 GMT
• DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• vivo opportunity (dbvt) holds 2.36m adss — 4.0% ownership disclosed Stock Titan Tue, 12 May 2026 07:00:00 GMT
• does dbv technologies' (enxtpa:dbv) esop-linked share shelf highlight a deeper funding strategy shift? simplywall.st Mon, 11 May 2026 07:00:00 GMT
• dbv technologies (nasdaq: dbvt) lines up 40 proposals for 2026 shareholder meeting Stock Titan Mon, 11 May 2026 07:00:00 GMT
DBV Technologies S.A(NASDAQ:DBVT) 
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergie...
Website: http://www.dbv-technologies.com
Founded: 2002
Full Time Employees: 311
Sector: Healthcare
Industry: Biotechnology